The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein

Retrovirology

Volumn 7, Issue , 2010, Pages

  Miyauchi, Kosuke ^a   Curran, A Rachael ^b   Long, Yufei ^c   Kondo, Naoyuki ^c,d,e   Iwamoto, Aikichi ^d   Engelman, Donald M ^b   Matsuda, Zene ^c,d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b YALE UNIVERSITY   (United States)

^c INSTITUTE OF BIOPHYSICS   (China)

^d UNIVERSITY OF TOKYO   (Japan)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN PRECURSOR; PROTEIN TAC; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; PEPTIDE;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS; INTRACELLULAR TRANSPORT; MEMBRANE FUSION; MEMBRANE SPANNING DOMAIN; MUTAGENESIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; SCANNING ALANINE INSERTION MUTAGENESIS; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; COCULTURE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SYNTHESIS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COCULTURE TECHNIQUES; COS CELLS; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78149338272     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-95     Document Type: Article

References (41)

1. Weiss CD. HIV-1 gp41: mediator of fusion and target for inhibition. AIDS Rev 2003, 5:214-221.
2. Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 2001, 70:777-810. 10.1146/annurev.biochem.70.1.777, 11395423.
3. Freed EO, Martin MA. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem 1995, 270:23883-23886. 10.1074/jbc.270.41.23883, 7592573.
4. Gu M, Rappaport J, Leppla SH. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett 1995, 365:95-97. 10.1016/0014-5793(95)00447-H, 7774724.
5. Moulard M, Decroly E. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochim Biophys Acta 2000, 1469:121-132.
6. Ohnishi Y, Shioda T, Nakayama K, Iwata S, Gotoh B, Hamaguchi M, Nagai Y. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol 1994, 68:4075-4079. 236921, 8189547.
7. McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, Weissman IL. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 1988, 53:55-67. 10.1016/0092-8674(88)90487-4, 2450679.
8. Kantanen ML, Leinikki P, Kuismanen E. Endoproteolytic cleavage of HIV-1 gp160 envelope precursor occurs after exit from the trans-Golgi network (TGN). Arch Virol 1995, 140:1441-1449. 10.1007/BF01322670, 7661695.
9. Gabuzda D, Olshevsky U, Bertani P, Haseltine WA, Sodroski J. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor. J Acquir Immune Defic Syndr 1991, 4:34-40.
10. Dimmock NJ. The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis. Rev Med Virol 2005, 15:365-381. 10.1002/rmv.476, 16106492.
11. Lu L, Zhu Y, Huang J, Chen X, Yang H, Jiang S, Chen YH. Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core. J Biol Chem 2008, 283:16723-16731. 10.1074/jbc.M801083200, 2423246, 18408000.
12. Haffar OK, Dowbenko DJ, Berman PW. Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J Cell Biol 1988, 107:1677-1687. 10.1083/jcb.107.5.1677, 2115321, 3053734.
13. Helseth E, Olshevsky U, Gabuzda D, Ardman B, Haseltine W, Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J Virol 1990, 64:6314-6318. 248812, 2243396.
14. Yue L, Shang L, Hunter E. Truncation of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein defines elements required for fusion, incorporation, and infectivity. J Virol 2009, 83:11588-11598. 10.1128/JVI.00914-09, 2772686, 19726514.
15. West JT, Johnston PB, Dubay SR, Hunter E. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity. J Virol 2001, 75:9601-9612. 10.1128/JVI.75.20.9601-9612.2001, 114531, 11559792.
16. Senes A, Engel DE, DeGrado WF. Folding of helical membrane proteins: the role of polar, GxxxG-like and proline motifs. Curr Opin Struct Biol 2004, 14:465-479. 10.1016/j.sbi.2004.07.007, 15313242.
17. Wilk T, Pfeiffer T, Bukovsky A, Moldenhauer G, Bosch V. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology 1996, 218:269-274. 10.1006/viro.1996.0190, 8615034.
18. Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol 2005, 79:4720-4729. 10.1128/JVI.79.8.4720-4729.2005, 1069530, 15795258.
19. Deml L, Kratochwil G, Osterrieder N, Knuchel R, Wolf H, Wagner R. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain. Virology 1997, 235:10-25. 10.1006/viro.1997.8669, 9300033.
20. Salzwedel K, Johnston PB, Roberts SJ, Dubay JW, Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1993, 67:5279-5288. 237926, 8102410.
21. Owens RJ, Burke C, Rose JK. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J Virol 1994, 68:570-574. 236324, 8254774.
22. Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z. Conformational changes of the HIV-1 envelope protein during membrane fusion were inhibited by the replacement of its membrane-spanning domain. J Biol Chem 2010, 285:14681-8. 10.1074/jbc.M109.067090, 20197275.
23. Miyauchi K, Curran R, Matthews E, Komano J, Hoshino T, Engelman DM, Matsuda Z. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions. Jpn J Infect Dis 2006, 59:77-84.
24. Shang L, Yue L, Hunter E. Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol 2008, 82:5417-5428. 10.1128/JVI.02666-07, 2395181, 18353944.
25. Ratner L, Fisher A, Jagodzinski LL, Liou RS, Mitsuya H, Gallo RC, Wong-Staal F. Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. Haematol Blood Transfus 1987, 31:404-406.
26. Andreassen H, Bohr H, Bohr J, Brunak S, Bugge T, Cotterill RM, Jacobsen C, Kusk P, Lautrup B, Petersen SB, et al. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods. J Acquir Immune Defic Syndr 1990, 3:615-622.
27. Pace CN, Scholtz JM. A helix propensity scale based on experimental studies of peptides and proteins. Biophys J 1998, 75:422-427. 10.1016/S0006-3495(98)77529-0, 1299714, 9649402.
28. Chakrabartty A, Schellman JA, Baldwin RL. Large differences in the helix propensities of alanine and glycine. Nature 1991, 351:586-588. 10.1038/351586a0, 2046766.
29. Welman M, Lemay G, Cohen EA. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. Virus Res 2007, 124:103-112. 10.1016/j.virusres.2006.10.009, 17129629.
30. Kim JH, Hartley TL, Curran AR, Engelman DM. Molecular dynamics studies of the transmembrane domain of gp41 from HIV-1. Biochim Biophys Acta 2009, 1788:1804-1812. 10.1016/j.bbamem.2009.06.011, 2730987, 19540828.
31. Ronchi P, Colombo S, Francolini M, Borgese N. Transmembrane domain-dependent partitioning of membrane proteins within the endoplasmic reticulum. J Cell Biol 2008, 181:105-118. 10.1083/jcb.200710093, 2287291, 18391072.
32. Sato K, Sato M, Nakano A. Rer1p, a retrieval receptor for ER membrane proteins, recognizes transmembrane domains in multiple modes. Mol Biol Cell 2003, 14:3605-3616. 10.1091/mbc.E02-12-0777, 196553, 12972550.
33. Reggiori F, Black MW, Pelham HR. Polar transmembrane domains target proteins to the interior of the yeast vacuole. Mol Biol Cell 2000, 11:3737-3749. 15033, 11071903.
34. Curran AR, Engelman DM. Sequence motifs, polar interactions and conformational changes in helical membrane proteins. Curr Opin Struct Biol 2003, 13:412-417. 10.1016/S0959-440X(03)00102-7, 12948770.
35. Cosson P, Lankford SP, Bonifacino JS, Klausner RD. Membrane protein association by potential intramembrane charge pairs. Nature 1991, 351:414-416. 10.1038/351414a0, 1827877.
36. Zhu P, Liu J, Bess J, Chertova E, Lifson JD, Grise H, Ofek GA, Taylor KA, Roux KH. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006, 441:847-852. 10.1038/nature04817, 16728975.
37. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S. Molecular architecture of native HIV-1 gp120 trimers. Nature 2008, 455:109-113. 10.1038/nature07159, 2610422, 18668044.
38. Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH. Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs. PLoS Pathog 2008, 4:e1000203. 10.1371/journal.ppat.1000203, 2577619, 19008954.
39. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988, 62:3779-3788. 253522, 3047430.
40. Pincus SH, Wehrly K, Chesebro B. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates. J Immunol 1989, 142:3070-3075.
41. Abacioglu YH, Fouts TR, Laman JD, Claassen E, Pincus SH, Moore JP, Roby CA, Kamin-Lewis R, Lewis GK. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses 1994, 10:371-381. 10.1089/aid.1994.10.371, 8068416.